Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 615

1.

Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer's disease.

Parbo P, Madsen LS, Ismail R, Zetterberg H, Blennow K, Eskildsen SF, Vorup-Jensen T, Brooks DJ.

Alzheimers Res Ther. 2020 Jan 2;12(1):3. doi: 10.1186/s13195-019-0574-0.

2.

Tau Tangles in Parkinson's Disease: A 2-Year Follow-Up Flortaucipir PET Study.

Hansen AK, Parbo P, Ismail R, Østergaard K, Brooks DJ, Borghammer P.

J Parkinsons Dis. 2020;10(1):161-171. doi: 10.3233/JPD-191774.

PMID:
31815700
3.

Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users.

Levin FR, Mariani JJ, Pavlicova M, Choi CJ, Mahony AL, Brooks DJ, Bisaga A, Dakwar E, Carpenter KM, Naqvi N, Nunes EV, Kampman K.

Drug Alcohol Depend. 2020 Jan 1;206:107700. doi: 10.1016/j.drugalcdep.2019.107700. Epub 2019 Nov 1.

PMID:
31753736
4.

Cholinergic denervation in patients with idiopathic rapid eye movement sleep behaviour disorder.

Gersel Stokholm M, Iranzo A, Østergaard K, Serradell M, Otto M, Bacher Svendsen K, Garrido A, Vilas D, Fedorova TD, Santamaria J, Møller A, Gaig C, Hiraoka K, Brooks DJ, Okamura N, Borghammer P, Tolosa E, Pavese N.

Eur J Neurol. 2019 Nov 14. doi: 10.1111/ene.14127. [Epub ahead of print]

PMID:
31725927
5.

An Inverse Agonist Ligand of the PTH Receptor Partially Rescues Skeletal Defects in a Mouse Model of Jansen's Metaphyseal Chondrodysplasia.

Noda H, Guo J, Khatri A, Dean T, Reyes M, Armanini M, Brooks DJ, Martins JS, Schipani E, Bouxsein ML, Demay MB, Potts JT Jr, Jüppner H, Gardella TJ.

J Bone Miner Res. 2019 Nov 6. doi: 10.1002/jbmr.3913. [Epub ahead of print]

PMID:
31693237
6.

Ageing and amyloidosis underlie the molecular and pathological alterations of tau in a mouse model of familial Alzheimer's disease.

Metaxas A, Thygesen C, Kempf SJ, Anzalone M, Vaitheeswaran R, Petersen S, Landau AM, Audrain H, Teeling JL, Darvesh S, Brooks DJ, Larsen MR, Finsen B.

Sci Rep. 2019 Oct 31;9(1):15758. doi: 10.1038/s41598-019-52357-5.

7.

Salt-inducible kinases dictate parathyroid hormone 1 receptor action in bone development and remodeling.

Nishimori S, O'Meara MJ, Castro CD, Noda H, Cetinbas M, da Silva Martins J, Ayturk U, Brooks DJ, Bruce M, Nagata M, Ono W, Janton CJ, Bouxsein ML, Foretz M, Berdeaux R, Sadreyev RI, Gardella TJ, Jüppner H, Kronenberg HM, Wein MN.

J Clin Invest. 2019 Dec 2;129(12):5187-5203. doi: 10.1172/JCI130126.

8.

Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.

Kim H, Wrann CD, Jedrychowski M, Vidoni S, Kitase Y, Nagano K, Zhou C, Chou J, Parkman VA, Novick SJ, Strutzenberg TS, Pascal BD, Le PT, Brooks DJ, Roche AM, Gerber KK, Mattheis L, Chen W, Tu H, Bouxsein ML, Griffin PR, Baron R, Rosen CJ, Bonewald LF, Spiegelman BM.

Cell. 2019 Jul 11;178(2):507-508. doi: 10.1016/j.cell.2019.06.028. No abstract available.

9.

Tau Aggregation Correlates with Amyloid Deposition in Both Mild Cognitive Impairment and Alzheimer's Disease Subjects.

Dani M, Wood M, Mizoguchi R, Fan Z, Edginton T, Hinz R, Win Z, Brooks DJ, Edison P.

J Alzheimers Dis. 2019;70(2):455-465. doi: 10.3233/JAD-181168.

PMID:
31256120
10.

Clinical implications of early caudate dysfunction in Parkinson's disease.

Pasquini J, Durcan R, Wiblin L, Gersel Stokholm M, Rochester L, Brooks DJ, Burn D, Pavese N.

J Neurol Neurosurg Psychiatry. 2019 Oct;90(10):1098-1104. doi: 10.1136/jnnp-2018-320157. Epub 2019 May 11.

11.

Abnormal Amyloid Load in Mild Cognitive Impairment: The Effect of Reducing the PiB-PET Threshold.

Ismail R, Parbo P, Hansen KV, Schaldemose JL, Dalby RB, Tietze A, Kjeldsen PL, la Cour SH, Qvist P, Gottrup H, Eskildsen SF, Brooks DJ.

J Neuroimaging. 2019 Jul;29(4):499-505. doi: 10.1111/jon.12629. Epub 2019 May 10.

PMID:
31074062
12.

Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia.

Chandler H, Brooks DJ, Hattersley G, Bouxsein ML, Lanske B.

Osteoporos Int. 2019 Aug;30(8):1607-1616. doi: 10.1007/s00198-019-04999-4. Epub 2019 May 3.

13.

Abaloparatide improves cortical geometry and trabecular microarchitecture and increases vertebral and femoral neck strength in a rat model of male osteoporosis.

Besschetnova T, Brooks DJ, Hu D, Nagano K, Nustad J, Ominsky M, Mitlak B, Hattersley G, Bouxsein ML, Baron R, Lanske B.

Bone. 2019 Jul;124:148-157. doi: 10.1016/j.bone.2019.04.025. Epub 2019 Apr 30.

PMID:
31051317
14.

Progressive loss of raphe nuclei serotonin transporter in early Parkinson's disease: A longitudinal 123I-FP-CIT SPECT study.

Pasquini J, Ceravolo R, Brooks DJ, Bonuccelli U, Pavese N.

Parkinsonism Relat Disord. 2019 Apr 5. pii: S1353-8020(19)30185-3. doi: 10.1016/j.parkreldis.2019.03.025. [Epub ahead of print]

PMID:
30981664
15.

Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).

Femminella GD, Frangou E, Love SB, Busza G, Holmes C, Ritchie C, Lawrence R, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, Archer H, Coulthard E, Underwood BR, Prasanna A, Koranteng P, Karim S, Junaid K, McGuinness B, Nilforooshan R, Macharouthu A, Donaldson A, Thacker S, Russell G, Malik N, Mate V, Knight L, Kshemendran S, Harrison J, Brooks DJ, Passmore AP, Ballard C, Edison P.

Trials. 2019 Apr 3;20(1):191. doi: 10.1186/s13063-019-3259-x.

16.

Dynamic 11C-PiB PET Shows Cerebrospinal Fluid Flow Alterations in Alzheimer Disease and Multiple Sclerosis.

Schubert JJ, Veronese M, Marchitelli L, Bodini B, Tonietto M, Stankoff B, Brooks DJ, Bertoldo A, Edison P, Turkheimer FE.

J Nucl Med. 2019 Oct;60(10):1452-1460. doi: 10.2967/jnumed.118.223834. Epub 2019 Mar 8.

17.

Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [18F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter.

Sridharan S, Raffel J, Nandoskar A, Record C, Brooks DJ, Owen D, Sharp D, Muraro PA, Gunn R, Nicholas R.

Mol Imaging Biol. 2019 Oct;21(5):935-944. doi: 10.1007/s11307-019-01323-8.

18.

Microglial activation in early Alzheimer trajectory is associated with higher gray matter volume.

Femminella GD, Dani M, Wood M, Fan Z, Calsolaro V, Atkinson R, Edginton T, Hinz R, Brooks DJ, Edison P.

Neurology. 2019 Mar 19;92(12):e1331-e1343. doi: 10.1212/WNL.0000000000007133. Epub 2019 Feb 22.

19.

Attenuation of dopamine-induced GABA release in problem gamblers.

Møller A, Rømer Thomsen K, Brooks DJ, Mouridsen K, Blicher JU, Hansen KV, Lou HC.

Brain Behav. 2019 Mar;9(3):e01239. doi: 10.1002/brb3.1239. Epub 2019 Feb 20.

20.

Widespread microglial activation in multiple system atrophy.

Kübler D, Wächter T, Cabanel N, Su Z, Turkheimer FE, Dodel R, Brooks DJ, Oertel WH, Gerhard A.

Mov Disord. 2019 Apr;34(4):564-568. doi: 10.1002/mds.27620. Epub 2019 Feb 6.

21.

Prevalence and duration of non-motor symptoms in prodromal Parkinson's disease.

Durcan R, Wiblin L, Lawson RA, Khoo TK, Yarnall AJ, Duncan GW, Brooks DJ, Pavese N, Burn DJ; ICICLE-PD Study Group.

Eur J Neurol. 2019 Jul;26(7):979-985. doi: 10.1111/ene.13919. Epub 2019 Mar 1.

22.

Successful control of a methicillin-resistant Staphylococcus aureus outbreak in a burn intensive care unit by addition of universal decolonization with intranasal mupirocin to basic infection prevention measures.

Kim JJ, Blevins MW, Brooks DJ, Stehle JR Jr, McLouth CJ, Viviano JP, Holmes Iv JH, Bischoff WE.

Am J Infect Control. 2019 Jun;47(6):661-665. doi: 10.1016/j.ajic.2018.11.016. Epub 2019 Jan 4.

PMID:
30616934
23.

The Future of Brain Imaging in Parkinson's Disease.

Helmich RC, Vaillancourt DE, Brooks DJ.

J Parkinsons Dis. 2018;8(s1):S47-S51. doi: 10.3233/JPD-181482. Review.

24.

Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.

Kim H, Wrann CD, Jedrychowski M, Vidoni S, Kitase Y, Nagano K, Zhou C, Chou J, Parkman VA, Novick SJ, Strutzenberg TS, Pascal BD, Le PT, Brooks DJ, Roche AM, Gerber KK, Mattheis L, Chen W, Tu H, Bouxsein ML, Griffin PR, Baron R, Rosen CJ, Bonewald LF, Spiegelman BM.

Cell. 2018 Dec 13;175(7):1756-1768.e17. doi: 10.1016/j.cell.2018.10.025. Erratum in: Cell. 2019 Jul 11;178(2):507-508.

25.

Loss of Intestinal Alkaline Phosphatase Leads to Distinct Chronic Changes in Bone Phenotype.

Kuehn F, Adiliaghdam F, Hamarneh SR, Vasan R, Liu E, Liu Y, Ramirez JM, Hoda RS, Munoz AR, Ko FC, Armanini M, Brooks DJ, Bouxsein ML, Demay MB, Hodin RA.

J Surg Res. 2018 Dec;232:325-331. doi: 10.1016/j.jss.2018.06.061. Epub 2018 Jul 18.

PMID:
30463736
26.

Comment on " In Vivo [18F]GE-179 Brain Signal Does Not Show NMDA-Specific Modulation with Drug Challenges in Rodents and Nonhuman Primates".

McGinnity CJ, Årstad E, Beck K, Brooks DJ, Coles JP, Duncan JS, Galovic M, Hinz R, Hirani E, Howes OD, Jones PA, Koepp MJ, Luo F, Riaño Barros DA, Singh N, Trigg W, Hammers A.

ACS Chem Neurosci. 2019 Jan 16;10(1):768-772. doi: 10.1021/acschemneuro.8b00246. Epub 2018 Oct 11.

PMID:
30346706
27.

Treatment With a Soluble Bone Morphogenetic Protein Type 1A Receptor (BMPR1A) Fusion Protein Increases Bone Mass and Bone Formation in Mice Subjected to Hindlimb Unloading.

Ko FC, Van Vliet M, Ellman R, Grasso D, Brooks DJ, Spatz JM, Conlon C, Aguirre JI, Wronski TJ, Bouxsein ML.

JBMR Plus. 2017 Oct 9;1(2):66-72. doi: 10.1002/jbm4.10012. eCollection 2017 Oct.

28.

The Effect of 40-Hz Light Therapy on Amyloid Load in Patients with Prodromal and Clinical Alzheimer's Disease.

Ismail R, Hansen AK, Parbo P, Brændgaard H, Gottrup H, Brooks DJ, Borghammer P.

Int J Alzheimers Dis. 2018 Jul 30;2018:6852303. doi: 10.1155/2018/6852303. eCollection 2018.

29.

Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.

Dani M, Wood M, Mizoguchi R, Fan Z, Walker Z, Morgan R, Hinz R, Biju M, Kuruvilla T, Brooks DJ, Edison P.

Brain. 2018 Sep 1;141(9):2740-2754. doi: 10.1093/brain/awy188.

PMID:
30052812
30.

In vivo quantification of glial activation in minipigs overexpressing human α-synuclein.

Lillethorup TP, Glud AN, Landeck N, Alstrup AKO, Jakobsen S, Vang K, Doudet DJ, Brooks DJ, Kirik D, Hinz R, Sørensen JC, Landau AM.

Synapse. 2018 Dec;72(12):e22060. doi: 10.1002/syn.22060. Epub 2018 Aug 12.

PMID:
30009467
31.

Does inflammation precede tau aggregation in early Alzheimer's disease? A PET study.

Parbo P, Ismail R, Sommerauer M, Stokholm MG, Hansen AK, Hansen KV, Amidi A, Schaldemose JL, Gottrup H, Brændgaard H, Eskildsen SF, Borghammer P, Hinz R, Aanerud J, Brooks DJ.

Neurobiol Dis. 2018 Sep;117:211-216. doi: 10.1016/j.nbd.2018.06.004. Epub 2018 Jun 11.

PMID:
29902557
32.

Simplifying [18F]GE-179 PET: are both arterial blood sampling and 90-min acquisitions essential?

McGinnity CJ, Riaño Barros DA, Trigg W, Brooks DJ, Hinz R, Duncan JS, Koepp MJ, Hammers A.

EJNMMI Res. 2018 Jun 11;8(1):46. doi: 10.1186/s13550-018-0396-2.

33.

In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study.

Knudsen K, Fedorova TD, Hansen AK, Sommerauer M, Otto M, Svendsen KB, Nahimi A, Stokholm MG, Pavese N, Beier CP, Brooks DJ, Borghammer P.

Lancet Neurol. 2018 Jul;17(7):618-628. doi: 10.1016/S1474-4422(18)30162-5. Epub 2018 Jun 1.

PMID:
29866443
34.

Role of Neuroinflammation in the Trajectory of Alzheimer's Disease and in vivo Quantification Using PET.

Edison P, Brooks DJ.

J Alzheimers Dis. 2018;64(s1):S339-S351. doi: 10.3233/JAD-179929. Review.

35.

Decreased noradrenaline transporter density in the motor cortex of Parkinson's disease patients.

Sommerauer M, Hansen AK, Parbo P, Fedorova TD, Knudsen K, Frederiksen Y, Nahimi A, Barbe MT, Brooks DJ, Borghammer P.

Mov Disord. 2018 Jul;33(6):1006-1010. doi: 10.1002/mds.27411. Epub 2018 May 24.

36.

How treatment improvement in ADHD and cocaine dependence are related to one another: A secondary analysis.

Levin FR, Choi CJ, Pavlicova M, Mariani JJ, Mahony A, Brooks DJ, Nunes EV, Grabowski J.

Drug Alcohol Depend. 2018 Jul 1;188:135-140. doi: 10.1016/j.drugalcdep.2018.03.043. Epub 2018 May 1.

37.

Longitudinal diffusion tensor imaging changes in early Parkinson's disease: ICICLE-PD study.

Minett T, Su L, Mak E, Williams G, Firbank M, Lawson RA, Yarnall AJ, Duncan GW, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn D, O'Brien JT.

J Neurol. 2018 Jul;265(7):1528-1539. doi: 10.1007/s00415-018-8873-0. Epub 2018 Apr 25.

PMID:
29696499
38.

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.

Mattsson N, Groot C, Jansen WJ, Landau SM, Villemagne VL, Engelborghs S, Mintun MM, Lleo A, Molinuevo JL, Jagust WJ, Frisoni GB, Ivanoiu A, Chételat G, Resende de Oliveira C, Rodrigue KM, Kornhuber J, Wallin A, Klimkowicz-Mrowiec A, Kandimalla R, Popp J, Aalten PP, Aarsland D, Alcolea D, Almdahl IS, Baldeiras I, van Buchem MA, Cavedo E, Chen K, Cohen AD, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gill KD, Gkatzima O, Grimmer T, Hampel H, Herukka SK, Johannsen P, van Laere K, de Leon MJ, Maier W, Marcusson J, Meulenbroek O, Møllergård HM, Morris JC, Mroczko B, Nordlund A, Prabhakar S, Peters O, Rami L, Rodríguez-Rodríguez E, Roe CM, Rüther E, Santana I, Schröder J, Seo SW, Soininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Verhey FRJ, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin ÅK, Wiltfang J, Vandenberghe R, Brooks DJ, Fladby T, Rowe CC, Drzezga A, Verbeek MM, Sarazin M, Wolk DA, Fleisher AS, Klunk WE, Na DL, Sánchez-Juan P, Lee DY, Nordberg A, Tsolaki M, Camus V, Rinne JO, Fagan AM, Zetterberg H, Blennow K, Rabinovici GD, Hansson O, van Berckel BNM, van der Flier WM, Scheltens P, Visser PJ, Ossenkoppele R.

Alzheimers Dement. 2018 Jul;14(7):913-924. doi: 10.1016/j.jalz.2018.02.009. Epub 2018 Mar 28.

PMID:
29601787
39.

Structural and functional properties of bone are compromised in amyotrophic lateral sclerosis mice.

Ko FC, Li J, Brooks DJ, Rutkove SB, Bouxsein ML.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Aug;19(5-6):457-462. doi: 10.1080/21678421.2018.1452946. Epub 2018 Mar 23.

40.

Parametric mapping using spectral analysis for 11C-PBR28 PET reveals neuroinflammation in mild cognitive impairment subjects.

Fan Z, Dani M, Femminella GD, Wood M, Calsolaro V, Veronese M, Turkheimer F, Gentleman S, Brooks DJ, Hinz R, Edison P.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1432-1441. doi: 10.1007/s00259-018-3984-5. Epub 2018 Mar 9.

41.

Extrastriatal monoaminergic dysfunction and enhanced microglial activation in idiopathic rapid eye movement sleep behaviour disorder.

Stokholm MG, Iranzo A, Østergaard K, Serradell M, Otto M, Bacher Svendsen K, Garrido A, Vilas D, Parbo P, Borghammer P, Santamaria J, Møller A, Gaig C, Brooks DJ, Tolosa E, Pavese N.

Neurobiol Dis. 2018 Jul;115:9-16. doi: 10.1016/j.nbd.2018.02.017. Epub 2018 Mar 6.

PMID:
29522818
42.

Nigrostriatal proteasome inhibition impairs dopamine neurotransmission and motor function in minipigs.

Lillethorup TP, Glud AN, Alstrup AKO, Mikkelsen TW, Nielsen EH, Zaer H, Doudet DJ, Brooks DJ, Sørensen JCH, Orlowski D, Landau AM.

Exp Neurol. 2018 May;303:142-152. doi: 10.1016/j.expneurol.2018.02.005. Epub 2018 Feb 8.

PMID:
29428213
43.

Open-label pilot study of injectable naltrexone for cannabis dependence.

Notzon DP, Kelly MA, Choi CJ, Pavlicova M, Mahony AL, Brooks DJ, Mariani JJ, Levin FR.

Am J Drug Alcohol Abuse. 2018;44(6):619-627. doi: 10.1080/00952990.2017.1423321. Epub 2018 Feb 8.

44.

Progression of tremor in early stages of Parkinson's disease: a clinical and neuroimaging study.

Pasquini J, Ceravolo R, Qamhawi Z, Lee JY, Deuschl G, Brooks DJ, Bonuccelli U, Pavese N.

Brain. 2018 Mar 1;141(3):811-821. doi: 10.1093/brain/awx376.

PMID:
29365117
45.

Observations on muscle activity in REM sleep behavior disorder assessed with a semi-automated scoring algorithm.

Jeppesen J, Otto M, Frederiksen Y, Hansen AK, Fedorova TD, Knudsen K, Nahimi A, Brooks DJ, Borghammer P, Sommerauer M.

Clin Neurophysiol. 2018 Mar;129(3):541-547. doi: 10.1016/j.clinph.2017.12.029. Epub 2017 Dec 28.

PMID:
29353182
46.

Evaluation of the noradrenergic system in Parkinson's disease: an 11C-MeNER PET and neuromelanin MRI study.

Sommerauer M, Fedorova TD, Hansen AK, Knudsen K, Otto M, Jeppesen J, Frederiksen Y, Blicher JU, Geday J, Nahimi A, Damholdt MF, Brooks DJ, Borghammer P.

Brain. 2018 Feb 1;141(2):496-504. doi: 10.1093/brain/awx348.

PMID:
29272343
47.

Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting.

Walsh RR, Krismer F, Galpern WR, Wenning GK, Low PA, Halliday G, Koroshetz WJ, Holton J, Quinn NP, Rascol O, Shaw LM, Eidelberg D, Bower P, Cummings JL, Abler V, Biedenharn J, Bitan G, Brooks DJ, Brundin P, Fernandez H, Fortier P, Freeman R, Gasser T, Hewitt A, Höglinger GU, Huentelman MJ, Jensen PH, Jeromin A, Kang UJ, Kaufmann H, Kellerman L, Khurana V, Klockgether T, Kim WS, Langer C, LeWitt P, Masliah E, Meissner W, Melki R, Ostrowitzki S, Piantadosi S, Poewe W, Robertson D, Roemer C, Schenk D, Schlossmacher M, Schmahmann JD, Seppi K, Shih L, Siderowf A, Stebbins GT, Stefanova N, Tsuji S, Sutton S, Zhang J.

Neurology. 2018 Jan 9;90(2):74-82. doi: 10.1212/WNL.0000000000004798. Epub 2017 Dec 13.

48.

Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.

Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, Chételat G, Molinuevo JL, Landau SM, Mattsson N, Kornhuber J, Sabri O, Rowe CC, Parnetti L, Popp J, Fladby T, Jagust WJ, Aalten P, Lee DY, Vandenberghe R, Resende de Oliveira C, Kapaki E, Froelich L, Ivanoiu A, Gabryelewicz T, Verbeek MM, Sanchez-Juan P, Hildebrandt H, Camus V, Zboch M, Brooks DJ, Drzezga A, Rinne JO, Newberg A, de Mendonça A, Sarazin M, Rabinovici GD, Madsen K, Kramberger MG, Nordberg A, Mok V, Mroczko B, Wolk DA, Meyer PT, Tsolaki M, Scheltens P, Verhey FRJ, Visser PJ; Amyloid Biomarker Study Group, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BNM, Blennow K, van Buchem MA, Cavedo E, Chen K, Chipi E, Cohen AD, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gkatzima O, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka SK, Johannsen P, Klimkowicz-Mrowiec A, Köhler S, Koglin N, van Laere K, de Leon M, Lisetti V, Maier W, Marcusson J, Meulenbroek O, Møllergård HM, Morris JC, Nordlund A, Novak GP, Paraskevas GP, Perera G, Peters O, Ramakers IHGB, Rami L, Rodríguez-Rodríguez E, Roe CM, Rot U, Rüther E, Santana I, Schröder J, Seo SW, Soininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin ÅK, Wiltfang J, Zetterberg H.

JAMA Psychiatry. 2018 Jan 1;75(1):84-95. doi: 10.1001/jamapsychiatry.2017.3391. Erratum in: JAMA Psychiatry. 2018 Mar 1;75(3):303.

49.

MAO-B Inhibitors Do Not Block In Vivo Flortaucipir([18F]-AV-1451) Binding.

Hansen AK, Brooks DJ, Borghammer P.

Mol Imaging Biol. 2018 Jun;20(3):356-360. doi: 10.1007/s11307-017-1143-1.

PMID:
29127552
50.

Organism-Level Analysis of Vaccination Reveals Networks of Protection across Tissues.

Kadoki M, Patil A, Thaiss CC, Brooks DJ, Pandey S, Deep D, Alvarez D, von Andrian UH, Wagers AJ, Nakai K, Mikkelsen TS, Soumillon M, Chevrier N.

Cell. 2017 Oct 5;171(2):398-413.e21. doi: 10.1016/j.cell.2017.08.024. Epub 2017 Sep 21.

Supplemental Content

Loading ...
Support Center